TFF3 and cancer: By receiver operating characteristics (ROC) curve analysis, TFF3 promoter hypomethylation was highly cancer-specific when comparing RP to BPH samples (area under the curve (AUC) 0.908, Figure 1C) and to AN samples (AUC 0.883, Figure 1D).